Literature DB >> 27414846

Relapsed Acute Lymphoblastic Leukemia Presenting as Optic Neuritis.

S A Fadilah1, A A Raymond2, S K Cheong1, A Faridah3.   

Abstract

Leukemic infiltration of the optic nerve is rare [1]. [Camera, A., Piccirillo, G., Tranfa, F., Rosa, N., Frigeri, F., Martinelli, V., Rotoloi, B. (1993) "Optic nerve involvement in acute lymphoblastic leukemia", Leuk. Lymph. 11, 153-155]. Radiotherapy should be given urgently to all patients with optic nerve infiltrate to restore their vision [2]. [Rosenthal, A. (1983) "Ocular manifestation of leukemia", Ophthalmology 90, 899-905]. We report a case of a unilateral optic nerve relapse 7 months after diagnosis of acute lymphoblastic leukemia (ALL) in a 17-year-old boy who had been off treatment for 6 weeks. The ocular symptoms was initially diagnosed as primary optic neuritis and treated with corticosteroids resulting in temporary clinical recovery. Radiation therapy for ocular leukemia that was commenced 2 months after the onset of symptoms failed to reverse the visual loss. The lack of a reliable and effective tool to diagnose ocular leukemia at an early stage has resulted in significant treatment delay and poor visual outcome.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Acute visual loss; Fine-needle aspiration (FNA); Ocular leukemia; Optic neuritis

Year:  2001        PMID: 27414846     DOI: 10.1080/10245332.2001.11752124

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  2 in total

1.  Vitreous cytology as the only diagnostic evidence of central nervous system involvement in a patient with isolated leukemic infiltrative optic neuropathy.

Authors:  Wen-Yi Wang; Chao-Wen Lin
Journal:  Taiwan J Ophthalmol       Date:  2021-03-09

2.  Case report: atypical, unilateral optic nerve infiltration as the first sign of acute lymphoblastic leukemia (ALL) relapse.

Authors:  Haidar Khalil; Clemens Strohmaier; Matthias Bolz
Journal:  BMC Ophthalmol       Date:  2022-04-27       Impact factor: 2.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.